Sarepta Therapeutics (SRPT) Cash from Investing Activities (2010 - 2026)
Sarepta Therapeutics' quarterly Cash from Investing Activities came in at -$134.4 million in Q1 2026, up 53.85% year-on-year from -$87.4 million in Q1 2025, and down 239.69% quarter-over-quarter from $96.2 million in Q4 2025.
Sarepta Therapeutics has reported Cash from Investing Activities for 17 years, with the latest figure at -$134.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 53.85% year-over-year to -$134.4 million; the trailing twelve-month figure through Mar 2026 stood at $226.4 million (down 7.8% YoY), and the FY2025 full-year result was $69.6 million, down 90.78% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$134.4 million, down from $96.2 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $764.1 million in Q4 2024, with the low at -$785.8 million in Q1 2022.
- Average Cash from Investing Activities over 5 years is -$30.7 million, with a median of $9.8 million recorded in 2022.
- Year-over-year, Cash from Investing Activities sank 1201.37% in 2023 and surged 1651.49% in 2024.
- Tracing SRPT's Cash from Investing Activities over 5 years: stood at $9.8 million in 2022, then sank by 756.98% to -$64.4 million in 2023, then jumped by 1287.29% to $764.1 million in 2024, then slumped by 87.41% to $96.2 million in 2025, then tumbled by 239.69% to -$134.4 million in 2026.
- The last three Cash from Investing Activities figures came in at -$134.4 million (Q1 2026), $96.2 million (Q4 2025), and $232.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -134.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.39 Mn |
| Mar 31, 2026 | -134.39 Mn |
| Dec 31, 2025 | 96.21 Mn |
| Dec 31, 2025 | 96.21 Mn |
| Sep 30, 2025 | 232.40 Mn |
| Sep 30, 2025 | 232.40 Mn |
| Jun 30, 2025 | 32.21 Mn |
| Jun 30, 2025 | 32.21 Mn |
| Mar 31, 2025 | -291.18 Mn |
| Mar 31, 2025 | -291.18 Mn |
| Dec 31, 2024 | 764.12 Mn |
| Dec 31, 2024 | 764.12 Mn |
| Sep 30, 2024 | -128.83 Mn |
| Sep 30, 2024 | -128.83 Mn |
| Jun 30, 2024 | -98.53 Mn |
| Jun 30, 2024 | -98.53 Mn |
| Mar 31, 2024 | 218.80 Mn |
| Mar 31, 2024 | 218.80 Mn |
| Dec 31, 2023 | -64.36 Mn |
| Dec 31, 2023 | -64.36 Mn |
| Sep 30, 2023 | -210.57 Mn |
| Sep 30, 2023 | -210.57 Mn |
| Jun 30, 2023 | 96.63 Mn |
| Jun 30, 2023 | 96.63 Mn |
| Mar 31, 2023 | 12.49 Mn |
| Mar 31, 2023 | 12.49 Mn |
| Dec 31, 2022 | 9.80 Mn |
| Dec 31, 2022 | 9.80 Mn |
| Sep 30, 2022 | 19.12 Mn |
| Sep 30, 2022 | 19.12 Mn |
| Jun 30, 2022 | -289.99 Mn |
| Jun 30, 2022 | -289.99 Mn |
| Mar 31, 2022 | -785.81 Mn |
| Mar 31, 2022 | -785.81 Mn |
| Dec 31, 2021 | -2.58 Mn |
| Dec 31, 2021 | -2.58 Mn |
| Sep 30, 2021 | 20.27 Mn |
| Sep 30, 2021 | 20.27 Mn |
| Jun 30, 2021 | 321.06 Mn |
| Jun 30, 2021 | 321.06 Mn |
| Mar 31, 2021 | 156.67 Mn |
| Mar 31, 2021 | 156.67 Mn |
| Dec 31, 2020 | -123.89 Mn |
| Dec 31, 2020 | -123.89 Mn |
| Sep 30, 2020 | 54.08 Mn |
| Sep 30, 2020 | 54.08 Mn |
| Jun 30, 2020 | -34.23 Mn |
| Jun 30, 2020 | -34.23 Mn |
| Mar 31, 2020 | -17.68 Mn |
| Mar 31, 2020 | -17.68 Mn |
| Dec 31, 2019 | 17.08 Mn |
| Dec 31, 2019 | 17.08 Mn |
| Sep 30, 2019 | -17.96 Mn |
| Sep 30, 2019 | -17.96 Mn |
| Jun 30, 2019 | 152.37 Mn |
| Jun 30, 2019 | 152.37 Mn |
| Mar 31, 2019 | 135.23 Mn |
| Mar 31, 2019 | 135.23 Mn |
| Dec 31, 2018 | -237.74 Mn |
| Dec 31, 2018 | -237.74 Mn |
| Sep 30, 2018 | -63.40 Mn |
| Sep 30, 2018 | -63.40 Mn |
| Jun 30, 2018 | -55.09 Mn |
| Jun 30, 2018 | -55.09 Mn |
| Mar 31, 2018 | -14.26 Mn |
| Mar 31, 2018 | -14.26 Mn |
| Dec 31, 2017 | -493.70 Mn |
| Dec 31, 2017 | -493.70 Mn |
| Sep 30, 2017 | 124.95 Mn |
| Sep 30, 2017 | 124.95 Mn |
| Jun 30, 2017 | -20.05 Mn |
| Jun 30, 2017 | -20.05 Mn |
| Mar 31, 2017 | 209.99 Mn |
| Mar 31, 2017 | 209.99 Mn |
| Dec 31, 2016 | -198.77 Mn |
| Dec 31, 2016 | -198.77 Mn |
| Sep 30, 2016 | 10.22 Mn |
| Sep 30, 2016 | 10.22 Mn |
| Jun 30, 2016 | 78.94 Mn |
| Jun 30, 2016 | 78.94 Mn |
| Mar 31, 2016 | 19.42 Mn |
| Mar 31, 2016 | 19.42 Mn |
| Dec 31, 2015 | -69.82 Mn |
| Dec 31, 2015 | -69.82 Mn |
| Sep 30, 2015 | 31.02 Mn |
| Sep 30, 2015 | 31.02 Mn |
| Jun 30, 2015 | 3.38 Mn |
| Jun 30, 2015 | 3.38 Mn |
| Mar 31, 2015 | 43.83 Mn |
| Mar 31, 2015 | 43.83 Mn |
| Dec 31, 2014 | 46.68 Mn |
| Dec 31, 2014 | 46.68 Mn |
| Sep 30, 2014 | -20.54 Mn |
| Sep 30, 2014 | -20.54 Mn |
| Jun 30, 2014 | -2.88 Mn |
| Jun 30, 2014 | -2.88 Mn |
| Mar 31, 2014 | -182.29 Mn |
| Mar 31, 2014 | -182.29 Mn |
| Dec 31, 2013 | -822,000.00 |
| Dec 31, 2013 | -822,000.00 |
| Sep 30, 2013 | -1.68 Mn |
| Sep 30, 2013 | -1.68 Mn |
| Jun 30, 2013 | -1.45 Mn |
| Jun 30, 2013 | -1.45 Mn |
| Mar 31, 2013 | -7.72 Mn |
| Mar 31, 2013 | -7.72 Mn |
| Dec 31, 2012 | -423,000.00 |
| Dec 31, 2012 | -423,000.00 |
| Sep 30, 2012 | -81,000.00 |
| Sep 30, 2012 | -81,000.00 |
| Jun 30, 2012 | -379,000.00 |
| Jun 30, 2012 | -379,000.00 |
| Mar 31, 2012 | -262,000.00 |
| Mar 31, 2012 | -262,000.00 |
| Dec 31, 2011 | -784,000.00 |
| Dec 31, 2011 | -784,000.00 |
| Sep 30, 2011 | -320,000.00 |
| Sep 30, 2011 | -320,000.00 |
| Jun 30, 2011 | -865,000.00 |
| Jun 30, 2011 | -865,000.00 |
| Mar 31, 2011 | -336,000.00 |
| Mar 31, 2011 | -336,000.00 |
| Dec 31, 2010 | -507,000.00 |
| Dec 31, 2010 | -507,000.00 |
| Sep 30, 2010 | -489,000.00 |
| Sep 30, 2010 | -489,000.00 |